Loading provider…
Loading provider…
Internal Medicine Physician in Tampa, FL
NPI: 1376599340Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get MD Jhanelle's Phone Numberphone_androidMobile
Get MD Jhanelle's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2004 - 2027
NY State Medical License
2003 - 2005

American Board of Internal Medicine
Medical Oncology
Weill Cornell Medicine
weill.cornell.edu
Medical School
Until 2001
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General Hospital
Fellowship • Hematology and Medical Oncology
2004 - 2007
New York Presbyterian Hospital (Cornell Campus)
Residency • Internal Medicine
2001 - 2004
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 33 | 56 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 22 | 22 |
Authors: Tawee Tanvetyanon, Alberto Chiappori, Eric Haura, Michael Shafique, Andreas Saltos, George Simon, Benjamin Creelan
Journal: J Thorac Dis
Publication Date: 2023-11-08
Authors: Gray, Jhanelle E, Schenker, Michael, Şendur, Mehmet Ali Nahit, Leonova, Viktoriya, Kowalski, Dariusz, Kato, Terufumi, Orlova, Rashida, Yang, James Chih-Hsin, Langleben, Adrian, Pilz, Arnold, Ungureanu, Andrei, Mak, Milena Perez, De Angelis, Flavia, Aggarwal, Himani, Zimmer, Zachary, Zhao, Bin, Shamoun, Mark, Kim, Tae Min
Journal: J Thorac Oncol
Publication Date: 2024-11-07
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Bristol-Myers Squibb, Jazz Pharmaceuticals
Intervention / Treatment: DRUG: Ipilimumab, DRUG: Nivolumab, DRUG: Lurbinectedin
Lead Sponsor: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Placebo, DRUG: Carboplatin, DRUG: Docetaxel, BIOLOGICAL: Nivolumab, DRUG: Cisplatin, DRUG: Paclitaxel, DRUG: Pemetrexed
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: DRUG: Nintedanib, DRUG: Ipilimumab, DRUG: Nivolumab